Lipid Nutrition Market Size, Share & Forecast to 2033

Technological Innovations and Rising Demand for Functional Nutrition to Drive Lipid Nutrition Market to USD 29.63 Billion by 2033 at 9.6% CAGR – Coherent Market Insights

The global lipid nutrition market was valued at US$ 15.6 Bn in 2026 and is expected to reach US$ 29.63 Bn by 2033, at a CAGR of 9.6% during the forecast period from 2026-2033 according to a Global Lipid Nutrition Market, by Product Type (Omega 3, Medium Chain Triglyceride, Omega 6, Long Chain Triglyceride, Omega 9, and Others), by Product Form (Liquid and Solid), by Source (Plant Extracts and Marine Sources), and by End-use Industry (Food & Beverages, Pharmaceuticals, Personal Care, Food Ingredients, and Others ).

Growing demand for lipids from the food & beverages industry, changing dietary habits of the consumers & rising inclination towards healthy food items, increasing integration of technologically advanced processes in the manufacturing of lipid nutrition products such as microencapsulation are some of the major factors fueling the market growth. Moreover, increasing awareness about the benefits associated with the consumption of lipid infused products coupled with rapid adoption of the lipids in curing cardiovascular diseases and obesity are some of the key factors propelling growth of the lipid nutrition market. However, rising prices for fish oils, wide availability of substitutes such as phytosterols, and low penetration of lipid infused products in the emerging economies are some of the major factors restraining growth of the lipid nutrition market.

Market Driver

Rising Awareness of Healthy Fats and Preventive Nutrition

Increasing recognition of the benefits of unsaturated fatty acids is increasing demand for omega-3, omega-6, medium-chain triglycerides, phospholipids, and other nutritional lipids.

For instance, in January 2026, the World Health Organization reiterated that unsaturated fats from fish, nuts, avocados, and vegetable oils are preferable to saturated and trans fats, supporting greater incorporation of healthy lipids into supplements, functional foods, and infant nutrition products. (Source: WHO)

Innovation in Lipid Delivery Formats and Bioavailability

Manufacturers are developing convenient, plant-based and high-absorption formats that overcome oxidation, poor taste, and dispersibility challenges.

For instance, in March 2026, SIRIO Europe, CDMO for nutrition products launched LifeChews, a plant-based jelly tablet for omega-3 oils and other lipid-soluble nutrients. The company reported that the technology achieved 161% higher plasma DHA concentration and a 198% improvement in bioavailability compared with the control format. (Source: SIRIO Europe)

Market Opportunity

Expansion Of Plant-Based and Sustainable Omega-3 Ingredients

Algae-derived DHA and EPA create significant opportunities among vegan, vegetarian, clean-label, and environmentally conscious consumers while reducing dependence on fish-based oils. For instance, in 2026, Aker BioMarine expanded the positioning of Revervia, a high-concentration algae-derived DHA ingredient designed for supplements, functional foods, and early-life nutrition applications. (Source: Reveria)

Development Of Convenient, High-Absorption Delivery Formats

Gummies, chewable tablets, emulsions, and smaller softgels can improve taste, swallowing convenience, nutrient stability, and consumer adherence, widening lipid nutrition adoption across children and adults. For instance, in March 2026, SIRIO Europe launched LifeChews, a plant-based chewable jelly tablet capable of delivering up to 400 mg of algae oil while reducing fishy taste and oxidation concerns. (Source: SIRIO Europe)

Market Trends

Growing adoption of algae-derived omega-3 ingredients: Manufacturers are shifting toward sustainable, vegan DHA and EPA sources that reduce dependence on marine fish oils. In July 2026, dsm-firmenich reported that two microalgae-based innovations from its life’s OMEGA portfolio were selected as finalists in the 2026 NutraIngredients-USA Awards.
Development of convenient lipid-delivery formats: Gummies, jelly tablets and chewable formats are gaining importance as brands seek to overcome swallowing difficulties, oxidation and unpleasant taste.
Demand for concentrated and formulation-efficient omega-3 products: High-potency DHA and EPA ingredients are gaining traction as manufacturers seek smaller serving sizes and improved formulation efficiency. In February 2026, GC Rieber VivoMega introduced Algae 1045 TG, a concentrated vegan DHA-and-EPA ingredient in triglyceride form for nutraceutical formulations.
Expansion of lipid nutrition into pet health applications: Algae-derived EPA and DHA are increasingly being incorporated into pet foods for joint, cognitive, skin and healthy-ageing support. In 2026, DSM-firmenich launched Veramaris O3 Max Pure, providing EPA and DHA in a 3:2 ratio as a fish-oil replacement for pet-food formulations.
Increasing focus on active and cognitive wellness: Lipid ingredients are increasingly positioned for brain health, physical performance, healthy ageing and everyday wellness rather than only cardiovascular support. In March 2026, Aker BioMarine launched its “Active Body, Active Mind” initiative combining Superba krill oil, Revervia algae-based DHA and Lysoveta brain-health ingredients. (Source: Aker BioMarine)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/lipid-nutrition-market-1027

Browse 180 market data tables* and 90 figures* on "Lipid Nutrition Market” - Global forecast to 2033.

Key Trends and Analysis of the Lipid Nutrition Market

Omega 3 and omega 6 segment together accounted for the largest market share of over 55% in 2026. Omega-3 and Omega 6 ingredients are widely used in medicated and non-medicated nutritional supplements. This is owing to several benefits such as superior speed, reflex, endurance, and overall enhancement of performance to athletes and recreational users. Such performance benefits to athletes is expected to fuel growth of these segments over the forecast period.
Plant extracts held a dominant position in 2026, owing to increasing use of plant-based lipids in processed food products. Plant lipids are more unsaturated than animal lipids and form more flavor during roasting or frying.

Key Takeaways of the Market

Asia Pacific is also projected as the fastest growing region in the global lipid nutrition market, witnessing a CAGR of 9.26% during the forecast period. Increasing adoption of lipid infused supplements for curing malnutrition and chronic diseases are major factors augmenting growth of the lipid nutrition market in the region. According to World Health Organization (WHO), in Indonesia, around 29% of deaths are caused by maternal & perinatal and nutritional deficiencies. Moreover, chronic diseases accounted for 61% deaths at all age groups in Indonesia.
Key players are developing advanced technologies to strengthen their lipid nutrition portfolios. For instance, in April 2026, Corbion received a U.S. patent for a liquid suspension technology containing algal biomass with a DHA-rich omega-3 profile. The technology, commercialized through AlgaPrime DHA LS, improves stability, handling, and formulation flexibility in aquaculture feed, animal nutrition, and pet food applications.

Key Development

In July 2026, Royal Canin launched its first fresh, fully cooked therapeutic diet portfolio for dogs in the U.S., available exclusively through veterinarians. The range includes formulas for gastrointestinal disorders, food sensitivities, reduced appetite, illness recovery, and unintended weight loss. The launch combines science-based therapeutic nutrition with the fresh-food format preferred by many pet owners, while giving veterinary professionals additional options for managing chronic canine health conditions through dietary management.
In April 2026, dsm-firmenich launched Veramaris O3 Max Pure at Petfood Forum 2026, introducing a microalgal oil designed to replace fish oil in pet-food formulations. The ingredient supplies EPA and DHA in a precise 3:2 ratio and is produced through closed-system fermentation. The non-GMO, vegan solution offers consistent quality, traceability, supply reliability, and sustainability while supporting brain, heart, joint, skin, and coat health in companion animals through advanced lipid nutrition. (Source: dsm-firmenich)
In March 2026, SIRIO Europe launched LifeChews, a patented plant-based jelly tablet designed for lipid-soluble nutrients. The format can deliver algal-oil DHA without a fishy taste or aftertaste. According to company-reported studies, LifeChews produced 161% higher plasma DHA concentration than the control, corresponding to a 198% improvement in bioavailability. Its 5-micrometre oil-droplet dispersion also supports absorption, formulation stability, and convenient supplementation across omega-3 and other lipid-based products for consumers worldwide.
In March 2026, Otsuka Pharmaceutical announced the renewal of Calorie Mate JELLY, with the updated range launching in Japan on March 16. The nutritionally balanced jelly provides protein, fat, carbohydrates, vitamins, and minerals in a convenient pouch. The refreshed portfolio includes Apple, Grapefruit, and Yogurt flavors, improved taste and texture, and redesigned packaging, supporting consumption before or after exercise, during busy periods, or when appetite is reduced among diverse consumers. (Source: Otsuka Pharmaceutical)